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Loneliness in Relation to Depression:
The Moderating Influence of a
Polymorphism of the Brain Derived
Neurotrophic Factor Gene on
Self-efficacy and Coping Strategies
Marc Bedard*, Robbie Woods, Carly Crump and Hymie Anisman
Department of Neuroscience, Carleton University, Ottawa, ON, Canada
Disturbances of brain derived neurotrophic factor (BDNF) signaling, which may occur
among those with a polymorphism of the Val66Met gene, comprising a Met substitution
for the Val allele, may be associated with depressive cognitions. However, presumed
elevated BDNF levels among individuals with the Val/Val genotype, might confer
increased responsivity to contextual challenges, thus fostering vulnerability to depression.
In Study 1, among undergraduate students (N = 252), increased loneliness perceptions
were accompanied with depressive symptoms. This relationship was moderated by
self-efficacy and BDNF genotype, such that when individuals appraised high self-efficacy,
those with the Val/Val genotype, compared to Met carriers, reported greater depression
scores when they perceived feeling lonely. Study 2 revealed that among undergraduate
students (N = 178), lower depressive scores were associated with increased
problem-focused coping among Val/Val individuals, but not Met carriers. Moreover, with
increased perceived loneliness, Val/Val carriers endorsed lower problem-focused coping.
Findings suggest that Val/Val individuals may have adverse neurocognitive vulnerability
to loneliness experiences.
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INTRODUCTION
Neurotrophins, including brain-derived neurotrophic factor (BDNF), that are fundamental for
neuronal plasticity and neurogenesis (Binder and Scharfman, 2004), may be expressed at lower
levels following stressor experiences (Duman, 2014). Likewise, there is evidence for a role of BDNF
in depressive disorders as serum concentrations of this neurotrophin may be diminished among
depressed individuals relative to controls (Shimizu et al., 2003; Wolkowitz et al., 2011; Bus et al.,
2015). Moreover, BDNF levels may predict depression severity, as lower BDNF levels may be found
among depressed individuals who are suicidal compared to those who are not suicidal (Kim et al.,
2007), and relapsed or recurrent-episode patients with major depression have lower BDNF levels
than those presenting with a first episode (Lee et al., 2007). Along the same line, antidepressant
treatment was linked to decreased depressive symptoms and elevations of BDNF serum levels
(Shimizu et al., 2003; Wolkowitz et al., 2011; Bus et al., 2015).
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A single nucleotide polymorphism of the BDNF gene,
rs6265, comprising a substitution of the amino acid valine
(Val) to methionine (Met) at codon 66 in the 5′ pro-region
(i.e., Val66Met), may lead to reduced activity-dependent BDNF
secretion and trafficking in cortical neurons (Egan et al., 2003;
Chen et al., 2004).Perhaps due to lower endogenous BDNF
levels, those with the Val66Met polymorphism exhibit greater
antidepressant response rates than do depressed individuals
homozygous for Val alleles (Zhou et al., 2010). Interestingly,
Met carriers may exhibit decreased synaptic plasticity in the
hippocampus (Egan et al., 2003) and prefrontal cortex (Liu et al.,
2012). Indeed, smaller hippocampal (Frodl et al., 2007;Molendijk
et al., 2012), and prefrontal gray-matter volumes (Kim et al.,
2013) have been observed, implicating the Val66Met gene in
cognitive processes, which may confer greater vulnerability to
depression.
The way individuals perceive and cope with stressor
experiences has been associated with depressive disorders.
For instance, the emergence and maintenance of depressive
disorders have been linked to the use of emotion-focused coping,
which may comprise emotional containment or expression,
blame, withdrawal, passive resignation, or avoidance, rather
than the use of problem solving, cognitive restructuring, active
distraction, or humor, which coping strategies coinciding with
a problem-focused orientation (Matheson and Anisman, 2003;
Caldwell et al., 2013). Thus, attention has been devoted to
evaluating whether differential use of particular coping styles
are linked to specific BDNF genotypes. It was reported that
Met carriers may be more likely to endorse emotion-focused
coping strategies (Caldwell et al., 2013), such as rumination
(Hilt et al., 2007; Beevers et al., 2009), which is often a
counterproductive method of coping with stressors (Nolen-
Hoeksema, 2000; Joormann et al., 2006) and has been predictive
of greater depressive symptomatology (Ravindran et al., 2002;
Matheson and Anisman, 2003; Thompson et al., 2010). This
is not to say that emotion-focused coping styles necessarily
foster depressive symptoms (Stanton et al., 1994), but greater
depression can be predicted in certain contexts, for instance,
if emotion-focused strategies are used in an inflexible manner
(Matheson and Anisman, 2003; Kelly et al., 2007; Nolen-
Hoeksema et al., 2008).
Feelings of loneliness have frequently been linked to
depressive disorders (Hawkley and Cacioppo, 2010; Cohen-
Mansfield et al., 2016), and may exacerbate existent depressive
symptoms (Cacioppo et al., 2006). It has been suggested that
this relationship may stem from a constellation of persistent
depressive cognitions that are tied to perceived social isolation
(Cacioppo and Hawkley, 2009), such as emotion-focused coping,
which may be employed to a much greater extent and in a more
inflexible manner (Revenson, 1980; Schoenmakers et al., 2015).
Similarly, disturbed mood might also arise from a lack of social
connectivity, which could be fundamental for effective coping
(Cruwys et al., 2014).
In addition to the endorsed use of particular coping styles,
depressive symptoms may also stem from decreased agency
to cope with adverse situations (Luszczynska et al., 2005).
Indeed, lower self-efficacy, which refers to perceptions of an
inability to cope with stressful or challenging environmental
situations (Luszczynska et al., 2005), has been associated with
both increased depression scores and feelings of loneliness (Wei
et al., 2005; Cohen-Mansfield et al., 2016). Moreover, feelings of
loneliness co-occurred with reduced white matter in several brain
regions, including the right anterior insula, bilateral inferior
parietal lobule, and dorsomedial prefrontal cortex, which are
believed to be linked to self-efficacy as well as social cognition
(Nakagawa et al., 2015). In effect, depressive symptoms may arise
out of an inability to cope with stressors, including feelings of
loneliness.
As the Met allele of the Val66Met gene may also be associated
with structural and functional changes of prefrontal cortical
areas (Liu et al., 2012; Kim et al., 2013), as well as decreased
white matter integrity in frontal lobe tracts (Ziegler et al.,
2013; Tatham et al., 2016), it might be reasonable to expect
that the BDNF genotype would moderate the relations between
loneliness, self-efficacy, and depression. This said, because BDNF
may serve as a neuroplasticity factor, it could be argued that
the influence of BDNF in relation to depressive symptoms could
vary with situational influences, as has previously been shown
with relations involving serotonin (Belsky et al., 2007, 2009).
From this perspective, those presumed to have adequate levels
of neuroplasticity may be differentially more sensitive to negative
life events (Belsky et al., 2007, 2009). Thus, decreased perceptions
of social isolation may have particularly adverse actions on
depressive symptoms among individuals with homozygous Val
alleles related to the gene for BDNF (Caldwell et al., 2013). As
such, it was of interest to assess whether the relationship between
loneliness and depression might vary with perceptions of self-
efficacy and coping methods used, and if these relationships
would be moderated by the Val66Met genotype, as reported in
other contexts (Hilt et al., 2007; Beevers et al., 2009; Caldwell
et al., 2013). In this regard, it was of interest to determine
whether loneliness experiences would be more closely linked to
the use of emotion-focused coping styles and poor self-efficacy
among Val/Val carriers, presumed to bemore sensitive to aversive
contexts.
MATERIALS AND METHODS
General Procedure
Following the provision of written informed consent,
participants completed a series of questionnaires to assess
current depressive symptoms, and perceptions of social isolation.
The present report comprised two studies, which were each part
of a larger investigation into gene polymorphisms as predictors
of depressive symptomatology. The larger investigation did
not involve measures of loneliness amongst all participants.
A questionnaire to assess demographic information was
administered to all participants, and Study 1 included a measure
to assess self-beliefs to cope with difficult situations, whereas
Study 2 measured the endorsement of particular coping styles.
Upon questionnaire completion, saliva was collected for the
analysis of DNA genotyping. Participants were subsequently
debriefed and provided with course credit. All procedures
were approved by the Carleton University Psychology Research
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Ethics Board, responsible for reviewing studies involving human
participants.
Genotyping
Saliva samples for genotyping were collected using Norgen Saliva
DNA Isolation Kits (Norgen Biotek Corp., Thorhold, Ontario,
Canada). Extraction of the genomic DNA from the sample
collection kit was conducted according to the manufacturer’s
instructions and diluted to approximately equal concentration
(20 ng/µL). DNA samples were then genotyped by McGill
University and Génome Québec Innovation Centre, Montréal,
Canada, where DNA was amplified using multiplex polymerase
chain reaction (PCR) followed by template-directed single base
extension. One probe per marker was used for template-directed
single base extension and the product was desalted using 6mg
of resin. The products were transferred to a 96-well chip by
Agena Bioscience nanodispenser, and then were crystalized with
a pre-spotted MALDI matrix. The chip was then read by mass
spectrometer (MALDI-TOFMS). The primers and probe used in
the amplification of the BDNF rs6265 gene during PCR were as
follows:
BDNF forward: ACGTTGGATGTACTGAGCATCACCCTG
GA
BDNF reverse: ACGTTGGATGGCTTGACATCATTGGCT
GAC
BDNF probe: TCCAACAGCTCTTCTATCA
STUDY 1
Participants
Participants consisted of 252 White/Euro-Caucasian Carleton
University undergraduate male (n = 73) and female (n= 179)
students with a mean age of 20.14 (SD = 4.87), who
were recruited through the university’s online computerized
recruitment system. A majority were living with friends or
roommates on (n = 75) or off-campus (n = 36), or were living
with parents (n = 87), with the rest reporting living alone
(n= 25), living with a significant other (n= 13), and 16 specified
other arrangements (e.g., living with another relative or with
children).
Measures
Depressive Symptoms
The Beck Depression Inventory (BDI; Beck et al., 1961) was
used to evaluate symptoms of depression. The BDI consists of
21 items corresponding to different depressive symptoms, and
for each item, participants selected one of four options, which
ranged from low to high symptomatology. Total scores were
calculated by summing across all items (α = 0.92), with higher
scores indicating greater depressive symptomatology.
Loneliness
Perceptions of loneliness and feelings of social isolation were
measured using the UCLA Loneliness Scale (Version 3; Russell,
1996). This 20-item scale consists of a list of statements, such as
“How often do you feel isolated from others?” or “How often do
you feel close to people?” Participants respond on a 4-point likert
scale ranging from 1 (never) to 4 (Always), to indicate how often
they felt as described by each of the items. Scores were summed
to create a total score (α= 0.95), such that higher scores indicate
more perceived loneliness.
General Self-efficacy
The 10-item General Self-Efficacy Scale (Schwarzer and
Jerusalem, 1995) was used to assess self-beliefs to cope with
difficult situations. Participants responded to items (e.g., “If I
am in trouble, I can usually think of a solution”) on a 4-point
likert scale ranging from 1 (not at all true) to 4 (exactly true).
Total scores were acquired by summing all items (α= 0.89), with
higher scores indicating greater degrees of self-efficacy.
Statistical Analyses
Statistical analyses were performed using SPSS version 21
(Armonk, NY, USA: IBM Corp.). All continuous variables were
checked for normality and were found to be acceptable with
the use of Q-Q plots, and through assessing skew statistics,
which remained between −2 and 2 (Curran et al., 1996).
Independent t-tests were performed to assess differences between
scores of depression, self-efficacy, and loneliness as a function
of BDNF genotype. Pearson correlations were used to evaluate
relations between perceived self-efficacy, depressive symptoms,
and loneliness, and relations among categorical variables were
analyzed with chi-squared tests. Moderations were analyzed
using hierarchical linear regressions, and significant moderations
were followed up using a web utility for simple slopes
(Preacher et al., 2006). Moderation analyses were conducted
using bootstrapping procedures to determine 95% confidence
intervals based on 5,000 resamples. Standardized scores were
used for all regression analyses. The significance level was set at
p< 0.05 for all analyses.
RESULTS
There were six participants for whom genotype could not
be determined based on the samples provided, so they were
excluded from analyses. Allele distribution for the Val66Met
polymorphism, rs6265, consisted of 5Met/Met (4 female, 1male),
71 Val/Met (47 female, 24 male), and 176 Val/Val (128 female,
48 male), which met Hardy-Weinberg Equilibrium expectations,
χ2
(2)
= 0.49, p = 0.780. As a result of the infrequency of the
Met/Met allele variant, data from both Val/Met and Met/Met
were collapsed together for analyses, as is the convention from
prior studies (Caldwell et al., 2013). Genotype distributions were
subsequently not found to differ as a function of gender, χ2
(1)
=
0.82, p= 0.367.
Moreover, depression scores were not found to differ between
Val/Val (M = 10.96, SE = 0.75) and the composite Val/Met and
Met/Met group (M = 10.22, SE = 1.09), t(250) = 0.55, p = 0.583,
95% CI = [−1.91, 3.394], d = 0.08. Similarly, loneliness did not
differ between Val/Val individuals (M = 42.18, SE = 0.94) and
the Met carriers (M = 42.38, SE = 1.27), t(250) = −0.12, p =
0.904, 95% CI = [−3.46, 3.06], d = 0.02. Those with the Val/Val
genotype (M = 30.24, SE = 0.42) were also not found to differ
fromMet carriers (M = 29.92, SE= 0.49) with respect to general
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self-efficacy, t(250) = 0.45, p = 0.653, 95% CI = [−1.08, 1.72],
d = 0.06.
Examination of bivariate relationships revealed that loneliness
was positively associated with depressive symptoms, r = 0.63,
p < 0.001, and negatively with self-efficacy scores, r = −0.51,
p < 0.001. In addition, general self-efficacy was negatively
related to depression scores, r = −0.58, p < 0.001. Thus,
it was of interest to examine whether self-efficacy moderated
the relationship between perceived loneliness and depressive
symptomatology. To this end, a hierarchical linear regression
was conducted with loneliness and self-efficacy in the first step,
followed with the loneliness x self-efficacy interaction term added
in the second step. These analyses revealed that self-efficacy
significantly moderated the relationship between loneliness and
depression, 1R2 = 0.02, b = −1.10, t = −2.82, p = 0.005. As
presented in Figure 1, follow-up simple slope analyses (Preacher
et al., 2006) indicated that although increased loneliness was
associated with greater depressive scores for both low and high
perceived self-efficacy, individuals with increased perceptions
of social isolation and that appraised a low ability to cope
with difficult situations exhibited more pronounced depressive
symptomatology [b = 5.62, SE = 0.66, t(248) = 8.57, p < 0.001]
than those who appraised a high ability to cope with difficult
situations [b = 3.43, SE = 0.63, t(248) = 5.47, p < 0.001]. The
relationship remained unchanged when age, gender and living
arrangement were entered as covariates.
As it was of interest to examine whether depression would
differ on levels of loneliness and self-efficacy as function of
BDNF genotype, a double-moderation was performed. Again,
hierarchical regression was performed in which loneliness, self-
efficacy, and BDNF were entered in the first step. In the second
FIGURE 1 | The relation between feelings of loneliness and depression scores
as a function of self-efficacy beliefs. Based on hierarchical linear regressions,
increased perceived loneliness was associated with elevated depressive
symptoms. Plotted separately as a function of low (1 SD below the mean) and
high scores (1 SD above the mean) of self-efficacy beliefs, this relationship was
more pronounced for those who appraised low self-efficacy, particularly at
elevated feelings of loneliness.
step, interaction terms for loneliness x self-efficacy, loneliness
× BDNF, and self-efficacy x BDNF were entered, followed by
the loneliness x self-efficacy × BDNF in the third step. Analyses
revealed a significant double moderation (Figure 2), 1R2 =
0.01, b = −2.23, t = −1.98, p = 0.049, such that lower
levels of self-efficacy were associated with an amplification of
depressive scores among those who perceived greater loneliness
experiences; however, simple slopes analyses with Bonferroni
correction indicated that although Val/Val individuals had
elevated depression scores at lower perceived loneliness if they
appraised low self-efficacy [b= 5.52, SE= 0.78, t(248) = 6.61, p<
0.001], those that had aMet allele exhibited the most pronounced
depressive symptoms with high loneliness experiences [b= 7.32,
SE = 1.30, t(248) = 5.62, p < 0.001]. At mean levels of general
self-efficacy, Val/Val individuals [b = 4.45, SE = 0.60, t(248) =
7.36, p < 0.001] and Met carriers [b = 4.33, SE = 0.97, t(248) =
4.48, p < 0.001] exhibited similar levels of depressive symptoms
in the presence of loneliness experiences, but interestingly, Met
carriers who appraised high levels in their ability to cope no
longer exhibited a significant relationship between loneliness and
depressive symptoms [b = 1.34, SE = 1.53, t(248) = 0.88, p =
0.382], whereas those with the homozygous Val allele exhibited a
marked increase in depression scores [b = 3.69, SE = 0.70, t(248)
= 5.27, p < 0.001]. Furthermore, the findings from the double
moderation did not differ when controlling for age, gender, and
living arrangement.
STUDY 2
It has been reported that compared to individuals homozygous
for the Val allele, Met carriers exhibited greater proclivity
to use emotion-focused coping strategies (Hilt et al., 2007;
Beevers et al., 2009; Caldwell et al., 2013), and the use of
emotion-focused coping was typically accompanied by more
pronounced depressive symptoms (Ravindran et al., 2002;
Matheson and Anisman, 2003; Thompson et al., 2010). However,
the moderating role of the BDNF genotype on relationships
between coping styles and depressive symptoms (when these
variables are included in the same analyses) has not previously
been examined.
In addition, Study 1 indicated that loneliness experiences
may be associated with lower self-efficacy to cope with difficult
situations. Moreover, there was a greater effect of loneliness on
depression scores in Val homozygotes in the context of high self-
efficacy, whereas Met carriers were more sensitive to increased
loneliness when they perceived low coping self-efficacy. It was
therefore of additional interest in Study 2 to examine whether
those with Val/Val alleles exhibit similar sensitivity to perceived
loneliness compared to Met carriers, and report increased use of
emotion-focused and decreased use of problem-focused coping
with increased loneliness.
Participants
Participants comprised of 178 White/Euro-Caucasian
undergraduate male (n= 50) and female (n= 128) students with
a mean age of 19.91 (SD = 5.62), who were recruited through
the University’s online computerized recruitment system. At
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FIGURE 2 | The moderational influences of BDNF genotype and self-efficacy beliefs on the relations between loneliness and depression. At 1 SD below the mean of
self-efficacy (A), depressive scores were more pronounced with increased loneliness experiences, particularly among Met carriers. At mean levels of self-efficacy
(B), depressive symptoms were similar, though slightly elevated among Val/Val individuals across loneliness perceptions. At 1 SD above the mean of self-efficacy (C),
Met carriers exhibited consistent depression scores across levels of social isolation, whereas those with homozygous Val alleles reported elevated depressive
symptoms with increased loneliness perceptions.
the time of assessment, a majority were living with friends or
roommates on (n = 59) or off-campus (n = 28), or were living
with parents (n = 58), with the rest reporting living alone
(n= 17), living with a significant other (n = 6), and 10 specified
other arrangements (e.g., living with a relative or with children).
Measures
In Study 2 participants completed the BDI (α = 0.89), and
the UCLA Loneliness Scale (α = 0.94), as described in the
preceding study. In addition, proclivity to use particular coping
strategies as ameans to deal with problems or recent stressors was
assessed through the 50-item Survey of Coping Profile Endorsed
(Matheson and Anisman, 2003), with responses recorded on a 5-
point likert scale from 0 (never) to 4 (almost always). A principal
components analysis with varimax rotation was conducted to
determine the underlying factor structure, with items being
included on a factor when factor loadings were greater than
0.32, as recommended by Tabachnick and Fidell (2013). This
revealed a two-factor solution, which encompassed emotion-
and problem-focused coping. Emotion-focused coping consisted
of wishful thinking, passive resignation, avoidance, emotional
containment, rumination, emotional expression, blaming others,
and self-blame (α= 0.82). Problem-focused coping comprised of
problem solving, cognitive restructuring, active distraction, and
humor (α= 0.69).
Statistical Analyses
Statistical analyses were performed using SPSS version 21
(Armonk, NY, USA: IBM Corp.). As in Study 1, Normality of
continuous variables was checked and found to be acceptable
with the use of Q-Q plots, and with skew statistics, which
remained between −2 and 2 (Curran et al., 1996). Independent
t-tests were performed to assess differences between scores of
depression, problem-focused and emotion-focused coping, and
loneliness as a function of BDNF genotype. Pearson correlations
were used to evaluate relations between problem-focused coping,
Frontiers in Psychology | www.frontiersin.org 5 July 2017 | Volume 8 | Article 1224
Bedard et al. BDNF, Loneliness, Coping, and Depression
emotion-focused coping, depressive symptoms, and loneliness,
and relations among categorical variables were analyzed with
chi-squared tests. Moderations were analyzed using hierarchical
linear regressions, and the significant moderations were followed
up using a web utility for simple slope analyses (Preacher et al.,
2006). The significance level was set at p< 0.05 for all analyses.
RESULTS
Allelic distribution for the Val66Met polymorphism consisted
of 4 Met/Met (3 female, 1 male), 41 Val/Met (28 female, 13
male), and 133 Val/Val (97 female, 36 male), which met Hardy-
Weinberg Equilibrium expectations, χ2
(2)
= 0.49, p = 0.924.
Subsequently, as in Study 1, data from both Val/Met andMet/Met
were pooled together for analyses. Genotype distributions did not
differ as a function of gender, χ2
(1)
= 0.27, p= 0.60.
As with Study 1, no differences were observed between Val/Val
(M = 8.75, SD = 7.66) and Val/Met and Met/Met groups
(M = 9.84, SD= 7.21), on depression scores t(176) = −0.84,
p = 0.404, 95% CI = [−3.67, 1.48], d = 0.15, or on perceived
loneliness (Val/Val, M = 41.56, SD = 11.29; Met carriers, M =
42.67, SD = 11.51), t(176) = −0.56, p = 0.574, 95% CI= [−4.96,
2.76], d = 0.10. Similarly, upon evaluation of coping styles,
Val/Val individuals (M = 1.95, SD = 0.62) did not differ from
Met carriers in terms of the use of emotion-focused coping, t(250)
= 0.276, p = 0.783, 95% CI = [−0.18, 0.24], d = 0.05, nor
did Val/Val individuals (M = 2.40, SD = 0.65) differ from Met
carriers (M = 2.28, SD= 0.54) on problem-focused coping, t(176)
= 1.12, p= 0.265, 95% CI= [−0.09, 0.33], d = 0.20.
An assessment of Pearson product moment coefficients
between study variables, once again revealed that loneliness
was positively associated with depressive symptoms, r = 0.63,
p < 0.001. As expected, a pattern emerged such that each of
loneliness (r = 0.55, p < 0.001) and depressive symptoms
(r = 0.61, p < 0.01) were positively associated with emotion-
focused coping, and negatively with the use of problem-focused
coping, (r =−0.21, p = 0.006, and r = −0.21, p = 0.006,
respectively).
As it was of interest to investigate whether an interaction
existed between BDNF genotype and coping styles in relation
to depressive symptoms, a hierarchical linear regression was
conducted with problem-focused coping and BDNF in the first
step, followed with the BDNF genotype x problem-focused
coping interaction in the second step. The analysis revealed
that BDNF genotype significantly moderated the relationship
between problem-focused coping and depression, 1R2 = 0.02,
b = 2.96, t(174) = 2.12, p = 0.036. As presented in Figure 3,
follow-up simple slope analyses (Preacher et al., 2006) indicated
that it was only for those with homozygous Val alleles that
greater use of problem-focused coping was associated with lower
depressive scores [b = −2.61, SE = 0.61, t(174) = −4.30, p <
0.001], whereas those who carried at least oneMet allele exhibited
consistent levels of depressive symptoms regardless of differing
use of problem-focused coping [b= 0.36, SE= 1.26, t(174) = 0.28,
p = 0.778]. An examination into the interaction between BDNF
genotype and emotion-focused coping on depressive scores was
FIGURE 3 | The relation between problem-focused coping and depression
scores was moderated by BDNF genotype. Simple slopes analyses indicated
that Met carriers exhibited consistent levels of depressive symptoms
regardless of the use of problem-focused coping. However, depressive
symptoms decreased among Val/Val carriers when more problem-focused
coping was reported.
not significant, [b = −0.42, t(174) = −0.41, p = 0.686]. Neither
of these relations were found to change when controlling for age,
gender, and living arrangement.
To evaluate whether coping styles, as predicted by loneliness
experiences, differed as a function of the BDNF genotype, further
hierarchical linear regressions were conducted with perceived
loneliness in the first step, and the loneliness x coping style (i.e.,
emotion-focused and problem-focused, in separate respective
analyses) interaction terms were added in the second step. These
analyses indicated that the BDNF genotype did not significantly
moderate the relation between loneliness and emotion-focused
coping [b = 0.03, t(174) = 0.35, p = 0.725], but a significant
interaction was evident between BDNF genotype and loneliness
in relation to problem-focused coping scores, 1R2 = 0.03, b =
0.24, t(174) = 2.28, p = 0.024. Follow-up simple slope analyses
(Figure 4), indicated that use of problem-focused coping was
greater at lower levels of perceived loneliness among those with
the Val/Val genotype, and that with increasing perceptions of
loneliness, the use of problem-focused coping was reduced [b =
−0.56, SE= 0.21, t(174) =−2.61, p= 0.01]. Among Met carriers,
the use of problem-focused coping did not differ with increased
loneliness experiences [b = 0.40, SE = 0.36, t(174) = 1.11, p =
0.270]. These findings did not differ when age, gender, and living
arrangement were entered as covariates.
DISCUSSION
Both depression and the Met allele of the Val66Met
polymorphism on the gene coding for BDNF may be
accompanied by reductions in structural and functional
connectivity of the hippocampus and prefrontal cortex (Frodl
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FIGURE 4 | The relation between perceived loneliness and depression scores
as a function of BDNF genotype. Simple slopes analyses indicated that Met
carriers did not differ in the use of problem-focused coping with increased
loneliness experiences. However, problem-focused coping was endorsed to a
greater extent with decreasing levels of perceived loneliness among those with
the Val/Val genotype.
et al., 2007; Molendijk et al., 2012; Kim et al., 2013; Ziegler et al.,
2013; Tatham et al., 2016), and BDNF concentrations in serum
have been linked to depressive disorders (Shimizu et al., 2003;
Wolkowitz et al., 2011; Bus et al., 2015). However, as evidence
for a direct relationship between BDNF genotype and depression
has not been consistently observed (Verhagen et al., 2010), it was
of interest to examine whether the Met polymorphism on the
BDNF gene would be associated with cognitive processes that
might confer greater vulnerability to depressive symptoms.
Interactions with Self-efficacy Appraisals
It is worth considering that certain stressors, including loneliness
experiences, may co-occur with or give rise to depressive
symptoms (Cacioppo et al., 2006; Hawkley and Cacioppo, 2010;
Cohen-Mansfield et al., 2016), which may also be engendered
through decreased self-efficacy to cope with stressful situations
(Wei et al., 2005; Nakagawa et al., 2015; Cohen-Mansfield
et al., 2016). Results from Study 1 (Figure 1) corroborated these
previous investigations, as individuals who reported more social
isolation exhibited elevated depressive symptoms if they also
felt that they lacked self-efficacy in their ability to cope with
difficult situations. Interestingly, the BDNF rs6265 genotype
moderated the relationship between depression, self-efficacy
and loneliness (see Figure 2). When individuals perceived
elevated self-efficacy, homozygous Val individuals exhibited
more pronounced depressive symptoms at high levels of
loneliness, whereas those with a Met allele did not demonstrate
a significant loneliness-depression relationship. Evidently, the
relationship between disturbances in neurotrophic signaling and
coping processes may not be as straightforward as previously
thought. In effect, the influence of the Val66Met gene coding
for BDNF seems to interact with psychological factors related
to stressful experiences and feelings of self-efficacy to cope with
difficult situations.
There is evidence that reduced BDNF secretion (Egan et al.,
2003; Chen et al., 2004), as well as altered functional and
structural connectivity of prefrontal cortical areas (Liu et al.,
2012; Kim et al., 2013) may be linked to Met carriers, which
may presumably render greater neurocognitive vulnerability to
depression. However, findings from the present investigation
seem contrary to that notion, and run against the prevailing
view that the greater availability of BDNF among homozygous
Val carriers may provide (although inconsistently noted)
neuroprotection against depressive symptoms (Verhagen et al.,
2010), as Study 1 did not reveal group differences on depression
scores as a function of BDNF genotype. The present findings
suggest that this relationship may be more nuanced, aligning
instead with the perspective that genes allowing for increased
neurotrophic support and thus enhanced neuroplasticity, would
be associated with strengthening of responses to both positive
and negative stimuli (Belsky et al., 2007, 2009). As such, the
presence of the Val/Val genotype, and hence the presence of
sufficient BDNF levels and greater neuroplasticity, may dispose
individuals to depressive symptoms in the context of perceiving
greater loneliness, despite the presence of high self-efficacy
appraisals (Figure 2C). In essence, these findings from Study
1 are consistent with the notion that relative to Met carriers,
individuals with the Val/Val genotype may be more sensitive to
adverse life experiences including loneliness, and thus are more
apt to report depressive symptomatology (Caldwell et al., 2013).
Influences on Coping Strategies
However, the actions of the Val66Met gene on relations with
depression may not simply be isolated to an appraised ability to
cope with difficult situations, and they may also extend to the
endorsed use of particular coping strategies. As was mentioned
earlier, previous studies had indicated that Met carriers might
be more likely to endorse emotion-focused styles (Hilt et al.,
2007; Beevers et al., 2009; Caldwell et al., 2013), which had
been presumed to be due to altered neuroplasticity. The findings
from Study 2, at least initially, were inconsistent with these
earlier data concerning the relationship between neurotrophic
disturbances and the use of specific coping processes, as
homozygous Val carriers were not found to differ from Met
carriers in relation to the use of either emotion- or problem-
focused coping. However, the data pointed to those with the
homozygous Val genotype being more likely to benefit from
problem-focused coping strategies, as they exhibited less affective
dysfunction (Figure 3). Given that those with homozygous
Val alleles did not differ from Met carriers on depressive
symptomatology, these data support the position that genes
coding for neurotrophins are aligned with enhanced proclivity
to adopt problem-focused coping, which may buffer against
depression (Ravindran et al., 2002;Matheson andAnisman, 2003;
Thompson et al., 2010).
Another stated aim of Study 2 was to separately investigate
actions of the Val66Met gene on relations between loneliness and
particular coping styles. There is mounting evidence supporting
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a role of neurotrophins in appraisals and coping in association
with stressor experiences (Beevers et al., 2009; Caldwell et al.,
2013). It had been reported that emotion-focused coping, which
was often an infective coping strategy to deal with stressors,
might be more apparent among Met carriers (Hilt et al., 2007;
Beevers et al., 2009; Caldwell et al., 2013). Study 2 extends these
earlier reports, as neurocognitive vulnerability was evident in
relation to the use of problem-focused coping among Val/Val
carriers at high levels of perceived social isolation (Figure 4).
Although Val/Val individuals reported greater use of problem-
focused coping at low levels of social isolation, this was no
longer evident with high feelings of loneliness. These data are
consistent with the evidence suggesting that neurotrophins may
be involved in appraisal and coping processes, and highlight
that negative contextual stressors, including feelings of loneliness,
may be most adverse for those with elevated neurotrophic
support.
Limitations
The present studies are subject to several limitations. As these
findings are based on cross-sectional data, any directionality
of variables assessed remains unclear, and so this may impact
interpretations of the variables of interest. For instance, it is
possible that depressive feelings may promote biased perceptions
pertinent to the self-reported social isolation and self-efficacy
appraisal measures. In addition, these studies made use of
Caucasian undergraduate students, and so caution is advised
against generalizability to other ethnic groups or circumstances.
Furthermore, the samples in both studies were limited and
included few individuals with the Met/Met genotype. Clearly,
a larger sample would have allowed for more precise analyses
to evaluate whether the differential susceptibilities evident in
the present investigations may be more graded based on Val
and Met allele combinations. It may also be argued that
as a number of the predictors are moderately correlated,
including loneliness with self-efficacy, and with emotion-
focused coping, multicollinearity may have influenced the results
and reduced statistical power (Tabachnick and Fidell, 2013).
However, standardized predictors were used in the regression
analyses, as is indicated to reduce the influence of collinearity.
Moreover, the results from the moderational analyses were not
found to differ when tested again with inclusion of squared
predictor terms as covariates, which alleviates concern of
confounding nonlinear effects associated with multicollinearity
(Cortina, 1993). Considered further, given that the patterns
of findings were similar across the two studies, it suggests
that the results presented in the present paper are tenable,
although future studies should seek to corroborate these
data.
CONCLUSIONS
With increasing evidence linking neurotrophins to appraisal and
coping processes, and the data indicating that negative situational
influences, including feelings of loneliness, may be especially
disturbing for those with elevated neurotrophic support. In
essence, the Val/Val allele variant is not necessarily always
advantageous, particularly in associations involving feelings of
loneliness and depression, and when other cognitive processes
are considered, Met carriers may exhibit greater resilience to
affective outcomes. This conclusion is in keeping with the view
previously expressed in relation to serotonin (Belsky et al., 2007,
2009) and oxytocin (McQuaid et al., 2013), that “for better or
worse” the Val/Val genotype for BDNF may increase sensitivity
and/or responsivity to environmental stimuli, and thus influence
mood state.
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